NewburyportNews.com, Newburyport, MA

Opinion

April 5, 2013

Our view: Time to end drug makers' 'pay for delay'

Americans struggling to meet health care costs know first-hand expensive prescription drugs can be. They may not know how drug companies often work together to keep costs artificially high.

The scheme is called “pay for delay.” Essentially, makers of brand-name drugs pay the makers of generic drugs not to challenge their patents or delay their attempts to make less-expensive alternatives. The brand-name makers then get to continue to charge whatever they want for the medicine, and the generic firms get a little cash for standing on the sidelines. The only losers in the deal are the patients who need the drugs and increasingly can’t afford them.

Writing in the Huffington Post, Laura Etherton, U.S. PIRG’s health care policy analyst, explained how the deals work:

“Brand name Plavix costs about $205 for a 30-day supply,” Etherton wrote. “The generic, not that it’s available, costs about $13. But consumers were stuck paying the higher price for far longer than they otherwise might have.

“That’s because in 2006, Bristol-Myers Squibb paid the generic drug maker Apoti to delay bringing the generic to market for five years,” Etherton continued. “Without competition, Bristol-Myers Squibb was able to keep making $3.4 billion a year in sales on the brand-name drug.”

The Federal Trade Commission says such deals violate the Sherman Antitrust Act and cost patients billions of dollars a year. In a case argued before the Supreme Court last week, the FTC argued that when Solvay Pharmaceuticals paid another company, Actavis, not to produce a less-expensive version of Solvay’s low-testosterone drug AndroGel, it constituted an unlawful restraint of trade. Not surprisingly, brand-name and generic drug makers have united to fight the lawsuit.

The pay for delay practice developed as a way to get around the 1984 Hatch-Waxman Act, which prodded generic drug makers to challenge patents on brand-name drugs, in the hopes of lowering costs for consumers.

Text Only | Photo Reprints

NDN Video
Obama: Putin must push separatists to aid MH17 probe Michigan inmates no longer allowed to wear orange due to 'OITNB' Adam Levine Ties the Knot Sebastian The Ibis Walks Beautiful Bride Down The Aisle | ACC Must See Moment NASA Ceremony Honors Moon Walker Neil Armstrong Faces of Souls Lost in Malaysian Plane Crash 105-year-old woman throws first pitch Man Creates Spreadsheet of Wife's Reasons for Turning Down Sex 'Weird Al' Is Wowed by Album's Success Rory McIlroy struggles, surges, wins British Open NOW TRENDING: Real life Pac-Man Explosions as hot air balloon crashes in Clinton DUI Driver Dragged to Safety by Officer After Walking Onto Busy Freeway Celebrities That We'd Like to Send to the Moon Spectacular lightning storm hits London Malaysian Flight Victim Was South Florida Grad Rory McIlroy on pace to break British Open records Officials Fear MH17 Site Now Tampered by Rebels Lowes employees repair Vietnam vet's wheelchair Widow of Staten Island man who died after NYPD takedown says he was unjustifiably targeted
Special Features
NRA Waterfront Plans